Sharon Shacham serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Sharon Shacham has executed 160 insider transactions totaling $20.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 12, 2015 involved selling 25,000 shares valued at $825.0K.
Sharon Shacham currently holds 958,131 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharon Shacham has been a net seller of KPTI stock. They have purchased $0 and sold $20.7M worth of shares.
Sharon Shacham's most recent insider trade was on Jan 12, 2015, when they sold 25,000 shares at $33.00 per share.
Get notified when new Form 4 filings are submitted
| $33.00 |
| Discretionary |
| Dec 1, 2014 | KPTI | $0 | Gift | 20,000 | $N/A | Discretionary |
| Jul 2, 2014 | KPTI | $4.3M | Sale | 100,000 | $42.50 | Discretionary |
| Jul 2, 2014 | KPTI | $4.3M | Sale | 100,000 | $42.50 | Discretionary |
| Jun 18, 2014 | KPTI | $431.5K | Sale | 10,000 | $43.15 | Discretionary |
| Jun 17, 2014 | KPTI | $403.6K | Sale | 10,000 | $40.36 | Discretionary |
| Dec 20, 2013 | KPTI | $0 | Gift | 82,750 | $N/A | Discretionary |
| Dec 20, 2013 | KPTI | $0 | Gift | 55,750 | $N/A | Discretionary |
| Nov 12, 2013 | KPTI | $0 | Conversion | 132,575 | $N/A | Discretionary |